These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 37664157)

  • 1. Huangqin decoction alleviates lipid metabolism disorders and insulin resistance in nonalcoholic fatty liver disease by triggering Sirt1/NF-κB pathway.
    Yan BF; Pan LF; Quan YF; Sha Q; Zhang JZ; Zhang YF; Zhou LB; Qian XL; Gu XM; Li FT; Wang T; Liu J; Zheng X
    World J Gastroenterol; 2023 Aug; 29(31):4744-4762. PubMed ID: 37664157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Huangqin decoction mitigates hepatic inflammation in high-fat diet-challenged rats by inhibiting TLR4/NF-κB/NLRP3 pathway.
    Yan BF; Wang Y; Wang WB; Ding XJ; Wei B; Liu SJ; Fu TM; Chen L; Zhang JZ; Liu J; Zheng X
    J Ethnopharmacol; 2023 Mar; 303():115999. PubMed ID: 36509260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
    Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
    World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
    Zhang J; Du H; Shen M; Zhao Z; Ye X
    J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patchouli alcohol ameliorates skeletal muscle insulin resistance and NAFLD via AMPK/SIRT1-mediated suppression of inflammation.
    Pyun DH; Kim TJ; Park SY; Lee HJ; Abd El-Aty AM; Jeong JH; Jung TW
    Mol Cell Endocrinol; 2021 Dec; 538():111464. PubMed ID: 34601002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chinese herbal medicine mixture 919 syrup alleviates nonalcoholic fatty liver disease in rats by inhibiting the NF-κB pathway.
    Chen M; Xing J; Pan D; Peng X; Gao P
    Biomed Pharmacother; 2020 Aug; 128():110286. PubMed ID: 32521450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Huangqin Decoction Attenuates DSS-Induced Mucosal Damage and Promotes Epithelial Repair via Inhibiting TNF-α-Induced NF-κB Activation.
    Gu LM; Li H; Xia JQ; Pan CY; Gu C; Tian YZ
    Chin J Integr Med; 2022 Feb; 28(2):124-129. PubMed ID: 34874516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LB100 ameliorates nonalcoholic fatty liver disease
    Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
    World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JianPi-QingHua formula attenuates nonalcoholic fatty liver disease by regulating the AMPK/SIRT1/NF-κB pathway in high-fat-diet-fed C57BL/6 mice.
    Tian J; Cai M; Jin S; Chen Q; Xu J; Guo Q; Yan Z; Han X; Lu H
    Pharm Biol; 2023 Dec; 61(1):647-656. PubMed ID: 37038833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrahydropalmatine ameliorates hepatic steatosis in nonalcoholic fatty liver disease by switching lipid metabolism via AMPK-SREBP-1c-Sirt1 signaling axis.
    Yin X; Liu Z; Wang J
    Phytomedicine; 2023 Oct; 119():155005. PubMed ID: 37562090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Betulin prevents high fat diet-induced non-alcoholic fatty liver disease by mitigating oxidative stress and upregulating Nrf2 and SIRT1 in rats.
    Farage AE; Abdo W; Osman A; Abdel-Kareem MA; Hakami ZH; Alsulimani A; Bin-Ammar A; Alanazi AS; Alsuwayt B; Alanazi MM; Antar SA; Kamel EM; Mahmoud AM
    Life Sci; 2023 Jun; 322():121688. PubMed ID: 37030617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A network pharmacology approach: Inhibition of the NF-κB signaling pathway contributes to the NASH preventative effect of an Oroxylum indicum seed extract in oleic acid-stimulated HepG2 cells and high-fat diet-fed rats.
    Sun W; Liu P; Yang B; Wang M; Wang T; Sun W; Wang X; Zheng W; Song X; Li J
    Phytomedicine; 2021 Jul; 88():153498. PubMed ID: 33640247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duodenal-jejunal bypass improves nonalcoholic fatty liver disease independently of weight loss in rodents with diet-induced obesity.
    Angelini G; Castagneto-Gissey L; Casella-Mariolo J; Caristo ME; Russo MF; Lembo E; Verrastro O; Stefanizzi G; Marini PL; Casella G; Bornstein SR; Rubino F; Mingrone G
    Am J Physiol Gastrointest Liver Physiol; 2020 Oct; 319(4):G502-G511. PubMed ID: 32812775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electroacupuncture Attenuates Liver Inflammation in Nonalcoholic Fatty Liver Disease Rats.
    Ma B; Li P; An H; Song Z
    Inflammation; 2020 Dec; 43(6):2372-2378. PubMed ID: 32737656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of bioactive components and synergistic action mechanism of ShuGan-QieZhi Capsule for treating non-alcoholic fatty liver disease.
    Zhu T; Huang X; Zhu H; Chen J; Yao H; Zhang Y; Hua H; Zhang J; Qi J
    Phytomedicine; 2024 Jan; 123():155173. PubMed ID: 37976695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pterostilbene and Its Derivative 3'-Hydroxypterostilbene Ameliorated Nonalcoholic Fatty Liver Disease Through Synergistic Modulation of the Gut Microbiota and SIRT1/AMPK Signaling Pathway.
    Tsai HY; Shih YY; Yeh YT; Huang CH; Liao CA; Hu CY; Nagabhushanam K; Ho CT; Chen YK
    J Agric Food Chem; 2022 Apr; 70(16):4966-4980. PubMed ID: 35416649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor binding protein 1 ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease.
    Pan J; Cen L; Zhou T; Yu M; Chen X; Jiang W; Li Y; Yu C; Shen Z
    J Gastroenterol Hepatol; 2021 Dec; 36(12):3438-3447. PubMed ID: 34273192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.
    Andrade JM; Paraíso AF; de Oliveira MV; Martins AM; Neto JF; Guimarães AL; de Paula AM; Qureshi M; Santos SH
    Nutrition; 2014; 30(7-8):915-9. PubMed ID: 24985011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1.
    Zhang Y; Geng C; Liu X; Li M; Gao M; Liu X; Fang F; Chang Y
    Mol Metab; 2017 Jan; 6(1):138-147. PubMed ID: 28123944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4/NF-κB signaling pathway.
    Wu HM; Ni XX; Xu QY; Wang Q; Li XY; Hua J
    J Gastroenterol Hepatol; 2020 Nov; 35(11):1998-2008. PubMed ID: 32128893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.